MedPath

CAM in Hospice Palliative Care in Taiwan

Not Applicable
Completed
Conditions
Cancer
Interventions
Device: SSP treatment
Registration Number
NCT02663063
Lead Sponsor
Taipei Veterans General Hospital, Taiwan
Brief Summary

The study aims to explore the effects of silver spike point (SSP) treatment on common symptoms including pain, breathlessness, nausea/vomiting, dry mouth etc. of terminal cancer patients.

Detailed Description

The study aims to explore the effects of silver spike point treatment on common symptoms including pain, breathlessness, nausea/vomiting, dry mouth etc. of terminal cancer patients. We will conducted a pilot study to evaluate the effects on different symptoms and then a prospective study will be conducted after validation of major effects.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Cancer patients
  • Competent with clear consciousness
  • With symptoms of pain, breathlessness, nause/vomiting, dry mouth, generalized discomfort
  • Expected life span of at least 1 week
Exclusion Criteria
  • With implanted devices
  • Not having clear consciousness
  • Expected life span less than 1 week
  • Foreigner

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SSP treatment groupSSP treatmentCase on SSP treatment
Non-SSP treatment groupSSP treatmentSham SSP treatment
Primary Outcome Measures
NameTimeMethod
Symptom severity scoreOne week after treatment

Questionnaire for evaluating the severity of symptoms

Secondary Outcome Measures
NameTimeMethod
Quality of lifeOne week after treatment

Questionnaire for evaluating quality of life

Trial Locations

Locations (1)

Taipei Veterans General Hospital

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath